Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Greenleaf currently holds 1,845,037 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Greenleaf has been a net seller of SCMP stock. They have purchased $104.6K and sold $4.8M worth of shares.
Peter Greenleaf's most recent insider trade was on Jan 2, 2026, when they sold 113,169 shares at $15.95 per share.
Peter Greenleaf serves as Executive at Sucampo Pharmaceuticals, Inc. (SCMP). They have executed 40 insider transactions totaling $4.9M over their tenure at the company.
Peter Greenleaf holds the position of Executive at Sucampo Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Peter Greenleaf has shown a selling trading pattern, with $104.6K in total purchases and $4.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Greenleaf was on Feb 13, 2018, when they sold $2.3M worth of SCMP shares. This transaction involved 129,729 shares at $18.00 per share.
Peter Greenleaf currently owns 1,845,037 shares of Sucampo Pharmaceuticals, Inc. (SCMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Greenleaf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Greenleaf has 40 Form 4 filings on record as an insider at Sucampo Pharmaceuticals, Inc..
Set alerts for Peter Greenleaf and 40,000+ other insiders.